Re: Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial
Open Access
- 3 August 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 97 (15), 1162-1163
- https://doi.org/10.1093/jnci/dji216
Abstract
The paper of Ragaz et al. ( 1 ) provides important level 1 evidence that the improvement in overall survival from the addition of postmastectomy radiotherapy to systemic therapy in axillary lymph node-positive patients, previously reported ( 2 ) , is sustained up to 20 years.Keywords
This publication has 4 references indexed in Scilit:
- More Evidence That Locoregional Radiation Therapy Improves Survival: What Should We Do?JNCI Journal of the National Cancer Institute, 2005
- Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized TrialJNCI Journal of the National Cancer Institute, 2005
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerNew England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997